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Introduction
Cataract still is a leading cause of
visual impairment worldwide (Abra-
ham et al. 2006). Despite the fact that
90% of cataracts in the world are
reported in developing countries, its
social, physical and economic impact is
still substantial in the developed world
(Resnikoff et al. 2004; Abraham et al.
2006). Cataract is a common cause of
visual impairment in the elderly that is
often noticed by patients at an early
stage, and surgery is often effective in
restoring vision (Foster 2001). Never-
theless, cataract surgery still remains a
major healthcare cost in Europe and
other Western countries.
Progressive ageing of the European
population is linked to the increase of
incidence and prevalence of cataract.
As an example, the general population
of Denmark is expected to increase by
10%, the proportion of the population
aged 70 or older is predicted to double
from 10.5% (2009) to 20.40% (2050),
and the number of cataract surgeries is
projected to correspondingly increase
from 46 000 in 2004 to 86 000 in 2050
(Rasanen et al. 2006). The increased
demand for cataract surgery may be
hard to meet in the future unless pre-
ventative actions are taken (Kessel
2011). Therefore, a review of modifi-
able risk factors of cataract and the
evaluation of aspects that affect total
costs of cataract surgeries is needed.
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ABSTRACT.
This literature review is aimed at the evaluation of the potential for cataract
prevention in Europe. It was performed using PubMed with Mesh and free-
text terms. Studies included were (i) performed on a population of Caucasian
origin at an age range of 40–95 years, (ii) cataract was clinically verified, (iii)
drug record of prescriptions, their indication, a record of every diagnosis, dos-
age and quantity of prescribed medicine were available, (iv) sample size >300
and (v) published between 1990 and 2009. The results of 29 articles were
reviewed. Former [3.75 (2.26–6.21)] or current smoking [2.34 (1.07–5.15)], dia-
betes of duration >10 years [2.72 (1.72–4.28)], asthma or chronic bronchitis
[2.04 (1.04–3.81)], and cardiovascular disease [1.96 (1.22–3.14)] increased the
risk of cataract. Cataract was more common in patients taking chlorproma-
zine during ‡90 days with a dosage ‡300 mg [8.8 (3.1–25.1)] and corticoster-
oids >5 years [3.25 (1.39–7.58)] in a daily dose >1600 mg [1.69 (1.17–2.43)].
Intake of a multivitamin ⁄mineral formulation [2.00 (1.35–2.98)] or corticoster-
oids [2.12 (1.93–2.33)] also increased the risk of cataract. Corticosteroids
applied orally [3.25 (1.39–7.58)], parenteral [1.56 (1.34–1.82)] or inhalational
[1.58 (1.46–1.71)] lead to cataract more frequently than those applied topi-
cally: nasal [1.33 (1.21–1.45)], ear [1.31 (1.19–1.45)] or skin [1.43
(1.36–1.50)]. Outpatient cataract surgery was negatively associated with total
cataract surgery costs, and chlorpromazine, corticosteroids and multivita-
min ⁄mineral formation increase the risk of posterior subcapsular cataract
dependent on dose, treatment application and duration. This review presented
a comprehensive overview of specific and general cataract risk factors and an
update on most recent experimental studies and randomized control trials
directed at cataract prevention.
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Cataract is a multifactorial disease
associated with age, female sex, genetic
predisposition, smoking, diabetes mell-
itus, drug intake and environmental
exposure to UVB radiation (Vrensen
2009). Previous reviews were often
focused on one of the aspects of cata-
ract epidemiology, such as common
risk factors (Taylor 1999; Abraham
et al. 2006; Navarro Esteban et al.
2007), the cost-effectiveness of different
treatment approaches (Chang 2005)
and their comparison between different
countries in Europe (Baltussen et al.
2004). Several epidemiological studies
report on cataract as a possible adverse
effect of widely used drugs (Ruigomez
et al. 2000; Smeeth et al. 2003); never-
theless, this aspect of cataract aetiology
was not reviewed previously. This liter-
ature review was undertaken to provide
an overview of cataract epidemiology,
cataract risk factors and cataract-
related economic burden as well as to




A literature search was performed in
the Medline database (PubMed) using
the following controlled vocabulary




AND ‘Drug Toxicity’[Mesh] and ‘Cat-
aract’[Mesh] AND ‘Risk Fac-
tors’[Mesh]; and the free-text search
terms ‘cataract’, ‘prevalence’, ‘inci-
dence’, ‘population-based’, ‘cross-sec-
tional’, ‘cohort studies’, ‘epidemiology’,
‘statistical data’, ‘adverse event’, ‘risk
factors’, ‘cataract surgery’, ‘surgical
activity’ and ‘costs’.
Only studies that used a standard-
ized definition of cataract were
included. Cataract was detected if
patients presented lens opacities, in
one or both eyes, with best corrected
visual acuity (VA) equal to 0.2 log
minimum angle of resolution (log-
MAR) (or 20 ⁄ 30 or 0.6) or worse.
Cataracts are subdivided into three
types: a) nuclear cataract, b) cortical
cataract and c) posterior subscapular
cataract (Cedrone et al. 1999).
The abstracts of the articles
identified were reviewed, and those
considered of high and medium rele-
vance were obtained. Additionally,
attention was also given to papers ref-
erenced in the selected articles. Special
attention was given to studies focusing
on prevalence and incidence by
age and gender, as cataract in the
industrialized countries primarily is an
age-related eye disease. Prevalence
quantifies the proportion of individu-
als in a population who have a disease
at a specific time-point. Incidence
quantifies the number of new events or
cases of the disease that develop in a
population of individuals at risk dur-
ing a specific time interval. Results are
shown here via a map of Europe for
crude prevalence values and a table
for cataract risk factors.
Results
Twenty-nine studies met the inclusion
criteria: two multicentre global popu-
lation-based studies (Foster 2001; Res-
nikoff et al. 2004), one case–control
study from Greece (Theodoropoulou
et al. 2011), five multicentre cross-sec-
tional European population-based
study (Das et al. 1994; Resnikoff et al.
2004; Simmons et al. 2007; Moshetova
2008), one Finnish nationwide popula-
tion-based survey (Laitinen et al.
2009), and thirteen prevalence popula-
tion-based studies: two from Rotter-
dam, the Netherlands (Klaver et al.
1998; Kocur & Resnikoff 2002), one
from the European North of Russia
(Bannikova et al. 2002), two from
France (Cohen et al. 2000; Waked
et al. 2007), three from Italy (Giuffre
et al. 1994; Cedrone et al. 1999; Ko-
cur & Resnikoff 2002), three from
Germany (Krumpaszky et al. 1999;
Trautner et al. 2003; Blum et al.
2007), one from Spain (Navarro Este-
ban et al. 2007), one from Bulgaria
(Kocur & Resnikoff 2002) and one
from Reykjavik, Iceland (Gunnlaugs-
dottir et al. 2010). Seven studies
describing cataract as an adverse
event of widely used drugs were
reviewed: three case–control from the
UK (Smeeth et al. 2003) and Spain
(Valero et al. 2002; OECD 2005); two
cohorts from the UK (Ruigomez et al.
2000) and Australia (Taylor 1999); an
observational population-based study
from France (Delcourt et al. 2000a,b);
and one randomized, double-masked,
placebo-controlled clinical trial (Ma-
raini et al. 2008).
Early cortical lens opacities and cataract
prevention
Adequate cataract extraction with
implantation of an intraocular lens is
recognized as the most effective
approach to prevent blindness from
cataract worldwide. However, it is
important to consider that this treat-
ment approach causes high economic
expenditure and can lead to postoper-
ative complications such as capsule
opacification, retinal detachment, end-
ophthalmitis, posterior capsular rup-
ture with vitreous loss, vitreous stands
to the surgical incision and iris pro-
lapsis through the corneal ⁄ limbal inci-
sion that may result in irreversible
blindness (Vrensen 2009). Therefore,
nonsurgical approaches for prevention
and treatment of cataract should be
given priority. More knowledge on
the aetiology of different types of cor-
tical, nuclear and posterior subcapsu-
lar cataracts (PSCs) in humans is
needed to formulate possible type-spe-
cific preventive strategies.
The accommodative power of the
lens declines after 40–50 years of age.
A constant increase in stray light
because of age-related lens changes
accounts for considerable glare that
sometimes can lead to disabling hand-
icaps, for example, during driving in
darkness (Sasaki et al. 1997). A yel-
lowish colour and smaller opacities in
the equatorial region are common
observations in older lenses (Truscott
2005). The number of opacities can
vary significantly from a few scattered
spots to shades, opaque segments or
full opaque annular rings (Vrensen
2009). Most of these opacities are
often located outside the pupillary
space and are not seen during slit-
lamp microscopy even in mydriasis.
Early opacities can take two forms,
which were first described by Obaza-
wa (1982)): (i) circular shades running
parallel to the circumference of the
lens and (ii) radial shades running per-
pendicular to the circumference of the
lens. Early or incipient opacities con-
sist of cohorts of disorganized lens
fibre cells located in the deep equato-
rial cortex of the lens and character-
ized by a high content of
phospholipids, cholesterol, disulphide
cross-linked proteins and free Ca++
Acta Ophthalmologica 2012
2
(Vrensen 2009). In a recent article,
Michael et al. (2008) emphasized that
the early opacities are the precursors
of a common type of cataract: age-
related cuneiform cortical cataract.
Studies on several hundreds of
donor’s lenses showed that the preva-
lence of spots and shades and of seg-
mental and annular opacities is
already considerable between the ages
of 30 and 45; at older ages, up to 75–
80% of the eye lenses exhibit this
form of early cataractous defect
(Vrensen 2009). The detrimental
effects of oxidative stress lead to local
ruptures of fibre membranes in the
superficial cortex at a relatively young
age (second or third decade). These
ruptures are repaired by internaliza-
tion and lysosomal breakdown of
the disordered membranes and pro-
teins (Vrensen & Willekens 1990). In
the fourth or fifth decade, local opaci-
ties occur in the deep equatorial cor-
tex close to the cortical–nuclear
barrier. These injuries are sealed by
‘nonleaky’ membranes that delay
progression into the pupillary cortex
and the nucleus of the lens (Vrensen
2009). Age-related cataracts are lar-
gely caused by lifelong accumulation
of oxidative insults, which, despite
the defence mechanism, eventually
lead to cortical and nuclear cataracts
rather late in life (Truscott 2005). Bal-
anced nutrition, rational use of an-
tioxidants and avoiding oxidation-
enhancing lifestyle factors such as
obesity, smoking, excessive drinking
and excessive exposure to UV light
are at the moment the best measures
to be taken to delay the onset of cata-
ract (Valero et al. 2002; Beebe et al.
2010).
Epidemiology of cataract in Europe
Cataract is a leading cause of blind-
ness globally accounting for 33% of
blindness worldwide (Pascolini &
Mariotti 2011). Global prevalence of
cataract in adults over 50 years of age
was estimated at 47.8% (Resnikoff
et al. 2004). Crude prevalence of cata-
ract in European adults in 2007 was
19.3% (Simmons et al. 2007). The
studies that are reviewed below repre-
sent the prevalence of lens opacifica-
tion and do not include patients who
underwent cataract surgeries. The pre-
sented prevalence rates highlight the
impact cataract on the population in
Europe.
The prevalence of cataract in Eur-
ope increased with age from 5% for
the 52–62 (Moshetova et al. 2008) and
30% for 60–69 years of age to 64%
for the population over 70 years (Das
et al. 1994). In a population-based
survey performed in Casteldaccia,
Italy, lens opacities of moderate or
severe grade were found at the follow-
ing crude rates: nuclear opalescence in
18.5%, cortical cataract in 12.9% and
PSC in 10.8% (Giuffre et al. 1994).
All these types of cataract were much
more frequent in the elderly popula-
tion and were about 1.5 times more
common in women than in men.
Advanced stages of cataract were
found in about 1 ⁄ 3 of subjects aged
60–69 years and in 2 ⁄3 of subjects
aged 70 or more, but only rarely in
subjects <60 years of age. Cataracts
causing a reduction in VA under 0.7
in the worst eye were found in 4% of
subjects 40–49 years old, 8.7% of sub-
jects 50–59, 21.5% of subjects 60–69
and 54.4% of subjects 70 years old or
over (Giuffre et al. 1994). In a study
from Lebanon, it was estimated that
cataract was the most frequent cause
of visual impairment in the region and
accounted for 38.5% of visually
impaired people (Waked et al. 2007).
A population-based study of blindness
incidence in Germany showed that
cataract accounted for 3.32 per
100 000 person-years (3.11–3.52) and
was the second most frequent cause of
blindness (Trautner et al. 2003). The
Reykjavik Eye study indicated that
cataract was a principal cause of uni-
lateral visual impairment, accounting
for 50% of cases (WHO criteria) to
65% of cases (US criteria) (Gunnl-
augsdottir et al. 2010). In contrast to
this, age-related cataract predomi-
nantly caused an increased prevalence
of visual impairment, but was not
among leading causes of blindness in
Rotterdam (Klaver et al. 1998). Cata-
ract, with a crude prevalence of 9.5%
(95% CI 8.9–10.2%), was the most
common chronic eye disease in the
Finnish population (Laitinen et al.
2009). About 53% of the Finnish pop-
ulation underwent cataract surgery.
This study also supports the fact that
the prevalence of cataract significantly
increased with age (p < 0.001), from
2% in persons under 65 years of age
to 67% in those aged 85 or older.
The highest overall cataract preva-
lence for adults was seen in Germany
(Blum et al. 2007) and Italy (Kocur &
Resnikoff 2002). A map of cataract
prevalence in Europe is shown in
Fig. 1.
Sex-specific cataract prevalence in a
Spanish study was higher in men over
64 years of age (69.50%) than in
women (65.50%) at the same age
(p > 0.05) (Navarro Esteban et al.
2007). The highest crude incidence of
cataract in adults was estimated to be
in Germany (0.20 per 100 000) (Kru-
mpaszky et al. 1999), followed by
Italy (0.065 per 100 000) (Cedrone
et al. 1999) and the European North
of Russia (0.039 per 100 000) (Arkh-
angelsk Oblast Administration et al.
2007).
Cataract risk factors
Cataract can develop because of many
factors, age being a constant sublimi-
nal modifier (Vrensen 2009). Former
or current smoking, diabetes of dura-
tion >10 years, asthma or chronic
bronchitis, and cardiovascular disease
increased the risk of cataract (Del-
court et al. 2000a,b). The recent
results of the Blue Mountains Eye
Study showed that baseline fasting
blood glucose level was associated
with the 10-year incidence of cortical
cataract [1.79 (1.25–2.57) for fasting
glucose ‡6.0 mm compared to fasting
glucose <6.0 mm]. This study also
underlined that each 1.0 mm increase
in fasting glucose was associated with
5-year progression of PSC [1.25,
(1.15–1.35)] and 10-year progression
of cortical [1.14, (1.01–1.27)] and
nuclear [1.20, (1.01–1.43)] cataract,
with no thresholds identified (Kan-
than et al. 2011). Cataract surgery
takes place approximately 20 years
earlier in patients with type 1 diabetes
in comparison with patients without
diabetes (Grauslund 2011). The popu-
lation-based cohort study of patients
with type 1 diabetes based on data
from the Danish patient registry
reported high 25-year cumulative inci-
dence of cataract surgery (20.8%)
(Grauslund et al. 2011). A case–con-
trol study performed in Greece also
showed that current or previous
smoking, a history of coronary heart
disease, a family history of ophthal-
mologic diseases and higher sunlight
exposure at the beach or at work sig-
nificantly increased the risk of cataract
(Theodoropoulou et al. 2011). Wear-
ing hats and sunglasses on the beach
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had a protective effect (Theodoropou-
lou et al. 2011). The link between
female gender and cataract remains
unclear. A nationwide Finnish survey
showed that cataract was more com-
mon in women than in men [1.55
(1.26–1.91)] (Laitinen et al. 2009),
whereas in a case–control study from
Greece, only borderline significance of
female gender was found for cortical
cataract (p = 0.06) (Theodoropoulou
et al. 2011). Interestingly, a prospec-
tive population-based study found no
significant longitudinal associations
between exogenous oestrogen expo-
sure, female reproductive factors and
the long-term incidence of cataract in
this older population-based cohort
(Kanthan et al. 2010). Modifiable risk
factors of cataract with adjusted odds
ratios are summarized in Table 1.
Cataract as an adverse event of widely
used drugs
Cataract appeared to be one of the
most frequent adverse events for
widely used drugs. Patients with
schizophrenia had the highest relative
cataract risk (Ruigomez et al. 2000).
Cataract was more common in
patients taking chlorpromazine during
‡90 days with a dosage ‡300 mg (Rui-
gomez et al. 2000), a multivita-
min ⁄mineral formulation (PSC)
(Maraini et al. 2008) or corticosteroids
(Smeeth et al. 2003). The highest risk
of cataract was detected for corticos-
teroids use >5 years in a daily dose
>1600 mg (Smeeth et al. 2003). Corti-
costeroids applied orally, parenteral
or inhalational lead to cataract more
frequently than those applied topi-
cally: nose, ear or skin (Smeeth et al.
2003). Detailed data on cataract as an
adverse effect of widely used drugs are
presented in Table 1.
Type-specific cataract risk factors
Knowledge of type-specific risk factors
of cataract is important for the inves-
tigation of possible type-specific
approaches to cataract prevention.
Nuclear cataract risk factors. Nuclear cat-
aracts are associated with poorer diet,
lower socio-economic status, nonpro-
fessional status and lower educational
achievement. The Age-Related Eye
Disease Study (AREDS) showed that
increasing age (hazard ratio (HR),
1.07; 95% CI, 1.06–1.09) is signifi-
cantly associated with increased
nuclear cataract, whereas female sex
was of borderline significance (HR,
Fig. 1. A map of cataract prevalence in Europe.
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1.12; 95% CI, 0.99–1.28) (Chang et al.
2011). A recent study reported an
increased incidence of cataract surgery
in subjects taking vitamin C supple-
ments (but not those taking multivita-
min supplements or diets high in
vitamin C) (Rautiainen et al. 2010).
The risk of nuclear cataracts also
increases with the amount and dura-
tion of smoking. Several studies iden-
tified larger lens size as a risk factor
for nuclear cataracts (Klein et al.
1998; Praveen et al. 2009). Longitudi-
nal studies confirmed that having a
larger lens is correlated with increased
risk of developing nuclear opacities
over a 5-year follow-up period (Klein
et al. 2000). Epidemiological studies
have also shown that living in a
region with increased ambient temper-
ature leads to the increased lens hard-
ening and risk of developing nuclear
cataract (Sasaki et al. 2002). Recent
laboratory investigations have sup-
ported this hypothesis (Heys et al.
2007). Genetic factors also play an
important role in the aetiology of
nuclear cataract. Studies on twins and
examination of familial associations
have suggested that about one-third
of the risk of nuclear cataracts is
hereditary (Heiba et al. 1993; Ham-
mond et al. 2000).
Cortical cataract risk factors. High sun-
light exposure has been consistently
associated with an increased risk of
cortical cataracts, although its contri-
bution to aetiology of other cataract











ratio, 95% CI References
Cardiovascular disease France 1995–1997 60–95 2584 Population-based
study








Female sex 3.03 (1.83–5.00)
Smoking (former smokers) 3.75 (2.26–6.21)








et al. (2011)Smoking (former smokers) 1.64 (1.02–2.70)






Higher sunlight exposure at
the beach
2.26 (1.37–3.72)
Use of cortisone drops 2.59 (0.93–7.21)
Higher sunlight exposure at
work
2.03 (1.32–3.12)




UK 2003 Over 40 15 476 Population-based
case–control
1.15 (1.03–1.27) Smeeth et al.
(2003)
Topical steroids, ear 1.31 (1.19–1.45)
Topical steroids, nasal 1.33 (1.21–1.45)
Topical steroids, other 1.35 (1.25–1.46)




Inhaled corticosteroids 1.58 (1.46–1.71)
Systemic steroids, oral 1.59 (1.47–1.71)
Daily dose of inhaled
corticosteroids >1600 mg
1.69 (1.17–2.43)
Ocular corticosteroids 2.12 (1.93–2.33)
Use of oral corticosteroids
at least 5 years




Lycopene, >0.30 mm Spain 2002 55–74 347 Case–control 1.43 (1.02- 2.06) Valero et al.




Multicentre 2008 55–75 1020 Randomized
controlled
trial
2.00 (1.35–2.98) Maraini et al.
(2008)
Chlorpromazine ⁄ current
use ‡90 day duration,
dosage ‡300 mg
UK 1992 30–85 4209 Cohort study 8.8 (3.1–25.1) Ruigomez
et al. (2000)






types is modest. Exposure to sunlight
can be effectively eliminated by wear-
ing a brimmed hat or plastic glasses,
making it a preventable risk (Taylor
et al. 1988). Females of African heri-
tage and those who have a family
member with cortical cataract have
more significant risk of developing
cortical cataracts (Leske et al. 1991,
1997; The Italian-American Cataract
Study Group 1991; McCarty et al.
2000; Hammond et al. 2001; Congdon
et al. 2005). Fifty to 60% of the risk
of developing cortical cataracts is
hereditary. Lens size was also identi-
fied as a significant risk factor for cor-
tical cataracts, but in contrast to
nuclear cataract, the increased preva-
lence and incidence of cortical opaci-
ties were linked to having a smaller
lens (Klein et al. 1998, 2000; Praveen
et al. 2009). The AREDS indicated
that increasing age (HR, 1.05; 95%
CI, 1.03–1.06), diabetes (HR, 1.31;
95% CI, 1.04–1.66), weight change of
middle quintiles (HR, 1.20; 95% CI,
1.00–1.43) and top quintile (HR, 1.35;
95% CI, 1.09–1.67) in comparison
with lowest quintile, smoking status
(current versus never) (HR, 1.41; 95%
CI, 1.09–1.83) and mild cortical cata-
ract at baseline (HR, 5.17; 95% CI,
4.29–6.22) are associated with an
increased risk of cortical cataract,
whereas male gender (HR, 0.83; 95%
CI, 0.72–0.95), white ethnicity (HR,
0.56; 95% CI, 0.42–0.75) and college
education (HR, 0.77; 95% CI, 0.66–
0.91) were associated with decreased
risk of cortical cataract (Chang et al.
2011).
Posterior subcapsular cataract. Several
studies have shown that patients with
diabetes have an increased risk of
developing cortical cataracts and
PSCs, although diabetes patients with
well-controlled blood sugar develop a
similar risk of age-related cataracts as
nondiabetics (Bron et al. 1993; Oishi
et al. 2006). Persons with uncontrolled
diabetes often rapidly develop cata-
racts. These opacities are associated
with osmotic damage to the superficial
lens cortex that may also involve oxi-
dative damage (Obrosova et al. 1999;
Hegde & Varma 2005). Other risk fac-
tors of PSCs are high myopia, diabe-
tes and exposure to therapeutic doses
of steroids and ionizing radiation.
Increasing age (HR, 1.06; 95% CI,
1.04–1.08), male gender (HR, 1.32;
95% CI, 1.11–1.58), diabetes (HR,
1.71; 95% CI, 1.29–2.27), increased
weight change (highest quintile versus
lowest quintile: HR, 1.48; 95% CI,
1.10–1.97) and thyroid hormone use
(HR, 1.37; 95% CI, 1.00–1.87) were
associated with increased risk of PSC,
whereas hyperopia was associated
with a decreased risk of PSC (HR,
0.78; 95% CI, 0.61–0.99) (Chang et al.
2011).
Common aetiology for all cataract
types. Oxidative damage is an impor-
tant aetiological factor for nuclear and
cortical cataracts. Substantial research
data suggest that, with increasing age,
the lens nucleus becomes more suscep-
tible to oxidation and less able to
repair oxidative damage (Truscott
2005). Absorption of UV light can
generate free radicals, leading to
increased oxidative damage (Wood &
Truscott 1993; Truscott 2003). Inter-
estingly, cortical cataracts first appear
at the lens equator, the region of the
lens that is best protected from expo-
sure to sunlight. This can be explained
by the absorption of UV light by other
eye tissues, the iris, for example, which
might produce toxic metabolites that
damage cortical fibre cells. Higher sun-
light exposure increases the stiffness of
the lens nucleus, and this increased
stiffness contributes to the formation
of cortical cataracts through mechani-
cal stress.
Potential sources of oxidative stress. Poten-
tial sources of oxidative stress to the
lens include UV light, oxidants in the
ocular fluids, endogenous oxidants
produced in lens cells and smoke con-
stituents. The increase in UV-absorb-
ing compounds in older lenses (‘UV
filters’) may increasingly sensitize the
lens to UV exposure (Mizdrak et al.
2008). Smoking is one of the most
reliable risk factors for nuclear cata-
racts in epidemiology studies through-
out the world (Hodge et al. 1995;
Cumming & Mitchell 1997; McCarty
et al. 2000; Age-Related Eye Disease
Study Research Group 2001). Expo-
sure to cooking fuel smoke has also
been linked to nuclear cataract (Pokh-
rel et al. 2005). The exact components
of smoke that cause oxidative stress,
however, are unknown.
Experimental evidence. Increased expo-
sure of the lens to oxygen is considered
to be a major cause of age-related
nuclear cataracts. This is supported by
several studies on patients undergoing
hyperbaric oxygen therapy that con-
firms the occurrence of a myopic shift,
even after relatively short-term therapy
(Fledelius et al. 2002; Evanger et al.
2004). Furthermore, this fact is sup-
ported by many studies on patients
undergoing vitrectomy. These studies
have documented very high rates of
nuclear cataract formation (60–95%)
within 2 years after vitrectomy surgery
(de Bustros et al. 1988; Cherfan et al.
1991; Van Effenterre et al. 1992;
Thompson et al. 1995). Studies during
which the vitreous gel was intentionally
preserved or destroyed highlighted that
vitreous gel protects the lens from oxy-
gen and from nuclear cataract. Loss of
the gel state of the vitreous is likely to
increase the exposure of the lens to oxy-
gen and increase the risk of nuclear cata-
ract (Shui et al. 2009). Vitrectomy
surgery is a frequently performed proce-
dure; therefore, patients undergoing this
operation can be a promising model to
test this hypothesis.
Cataract prevention
Although in the majority of cataract
patients vision can be restored to a
satisfactory level by surgically remov-
ing the natural lens and substituting it
with a lens made of synthetic poly-
mers, the incidence of cataract is so
large that surgery alone has been
found ineffective in solving this prob-
lem. Cataract remains a consistent
public health problem because of a
shortage of surgical facilities especially
in developing countries as well as the
continuous replacement of old cases
with new ones because of ageing and
population growth. Cataract extrac-
tion can lead to surgical and postsur-
gical complications, such as vitreous
loss, macular oedema and retinal
detachment, which are known to
occur in 5% of patients undergoing
cataract surgeries (Clayman 1982;
Stark et al. 1984; Smith et al. 1987).
Therefore, development of pharmaco-
logical means of cataract prevention
should be one of the main priorities
for future cataract research.
Randomized controlled trials for cataract
prevention
The preventive effects of vitamins E
and C on age-related cataract were




(RCT) in a large population of male
physicians (Christen et al. 2010). This
study also included longitudinal data
regarding influence of treatment with
vitamins E and C on cataract inci-
dence and cataract extraction. Treat-
ment with vitamin E showed no
significant influence on incidence of
nuclear (HR, 0.99; 95% CI, 0.88–
1.11), cortical (HR, 0.96; 95% CI
0.80–1.15) and posterior subcapsular
(HR, 0.95; 95% CI 0.77–1.18) cata-
ract and cataract extraction. There
were no apparent benefit of vitamin E
at any point during the trial and no
significant effects of vitamin C on the
incidence of nuclear (HR, 1.01; 95%
CI, 0.89–1.14), cortical (HR, 1.10;
95% CI 0.92–1.31) or posterior sub-
capsular (HR, 0.94; 95% CI 0.76–
1.17) cataract and cataract extraction.
Overall, results of this RCT from a
large population of middle-aged and
older, generally well-nourished men
exclude any large effect of long-term
dietary supplementation with vitamins
E and C on diagnosed cataract extrac-
tion. AREDS, a double-masked clini-
cal trial, showed no statistically
significant effect of the antioxidant
formulation on the development or
progression of age-related lens opaci-
ties (OR = 0.97, p = 0.55), as well as
no statistically significant effect of
treatment in reducing the risk of pro-
gression for any of the three lens
opacity types or for cataract surgery
(AREDS 2001). The Roche European
American Cataract Trial (REACT)
demonstrated a small but statistically
significant deceleration of cataract
progression because of the antioxidant
micronutrients, vitamins C and E and
the carotenoids (Schalch & Chylack
2003). It was noted that the tech-
niques for following the course of a
cataract in the REACT study were
more sensitive to subtle changes than
those used in the AREDS; further-
more, the REACT study intervention
started earlier in the disease process,
with higher doses of vitamins C and E
and beta-carotene (Schalch & Chylack
2003). The REACT results support
the early complementation of a diver-
sified diet with supplements containing
vitamins C and E and beta-carotene
as well as other carotenoids as a pre-
ventive measure as well as during the
early stages of cataract.
The information on nonsteroidal
anti-inflammatory drugs (NSAID)
and cataract risk is conflicting. Earlier
studies suggest preventive effect of
NSAIDs or aspirin on prevalence of
cataract and cataract surgery (van
Heyningen & Harding 1986; Harding
& van Heyningen 1988; Klein et al.
2001), whereas others do not indicate
any association (Chew et al. 1992;
Hankinson et al. 1993). Most recent
analysis of data from the AREDS
reports the association between
NSAID intake and increased risk of
cataract surgery and no influence on
prevalence of three major types of cat-
aract (Chang et al. 2011). The effect
of NSAID should be further studied
in order to clarify its effect on the risk
of cataract.
In vitro studies for cataract prevention
In vitro studies showed that tempol is
an effective radioprotective agent (Sa-
saki et al. 1998). It also has a capability
of inhibiting many of the processes
implicated in generating the oxidative
stress thought to be central to cata-
ractogenesis. It is cell permeable and
has been shown to penetrate the
blood ⁄brain and blood ⁄ aqueous barri-
ers. A reduced form of tempol (tempol-
H) has been found to have antioxidant
effects on cells exposed to H2O2. The
study on rat lenses supported the hyp-
nosis that tempol-H protects the lenses
from loss of transparency and from
deterioration of crucial biochemical
parameters including glutathione con-
centration and membrane transport
capacity (Zigler et al. 2003).
A study of possible inhibition of
oxidative stress and cataract forma-
tion by caffeine in mice with selenite-
induced cataracts (Varma et al. 2010)
showed that lenses of the pups iso-
lated from the caffeine-untreated
group developed highly advanced
opacities by day 20, whereas in the
group treated with caffeine, cataracto-
genesis was highly attenuated in a
majority of the lenses. Cataract devel-
opment was significantly inhibited in
the majority of pups treated with caf-
feine. No advanced cataract developed
at least in the majority (64%) of this
group. The effectiveness of caffeine
was related to its ability to prevent
oxidative stress to the tissue and con-
sequent maintenance of tissue metabo-
lism. Current observation showed that
caffeine could have a generalized anti-
cataractogenic effect when used phar-
macologically. This effect can be
achieved by its topical application,
which avoids potential systemic side-
effects. There are no clinical trials in
humans that investigated the associa-
tion between caffeine intake and risk
of cataract; therefore, further random-
ized control studies with application
of appropriate cataract identification
techniques such as photography of the
anterior eye segment according to
Scheimpflug’s principle (Wegener &
Laser-Junga 2009) are required to
investigate potential preventive effects
of caffeine in humans.
Photography of the Anterior Eye Segment
According to Scheimpflug’s Principle for
RCTs
During ageing, the layers of the lens
become more pronounced, so that
light scattering does not increase
homogeneously but specific layers
scatter more light than others. As a
result, there are typical lens light scat-
tering profiles for every decade of
human life expectancy. Further
increase in light scattering in the lens
leads to cataract development. Sche-
impflug photography and densitomet-
ric image analysis are very precise
techniques for light scattering mea-
surement and biometry in the anterior
segment of the eye. They provide
reproducible data on the characteris-
tics of the anterior eye segment in
clinical and experimental studies, and
the set of data obtained allows dis-
crimination of light scattering changes
because of ageing. Major epidemiolog-
ical studies dealing with ocular pathol-
ogies in the anterior eye segment use
either simple cataract classifications
systems (LOCS III) or the Scheimpf-
lug technique (Leibowitz et al. 1980;
Mitchell et al. 1997; Arnarsson et al.
2002). Scheimpflug photography is
more objective and less dependent on
the skills of the person performing the
examination. Scheimpflug photogra-
phy is more precise and objective than
LOCS III or other classification
systems because it relies on the densi-
tometric features of cataract develop-
ment rather than morphological
features. Another field of its applica-
tion is the monitoring of therapeutic
(side-) effects; therefore, this method
should be used as a preferred tech-
nique for cataract diagnosis and fol-
low-up procedure for RCT on
cataract prevention. A detailed over-
view of photography of the anterior
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eye segment according to Scheimpf-
lug’s principle was published by We-
gener & Laser-Junga (2009).




patients’ quality of life because of a
significant decrease in VA (Heijl &
Leske 2007). Surgery to remove the
opacified lens is considered to be the
only appropriate treatment for cata-
ract (Baltussen et al. 2004). Other
methods such as medications or diet
have not been shown to stop cataract
progression (Chang 2005). As cataract
has a high impact on quality of life of
patients, there were a number of
attempts to introduce qualitative mea-
sures of assessment in patients await-
ing cataract surgery in order to
identify patients with potentially bet-
ter prospective surgery outcomes.
During the Pyhajarvi Cataract Study
II, it was proposed to formulate selec-
tion criteria for cataract surgery that
will lead to the best possible outcomes
(Kuoppala et al. 2010). In addition to
objective signs such as the presence of
VA decrease and the opacification of
the lens, the authors of this study
proposed to add two global questions:
one on the subjective view on disabil-
ity and one on a more neutral view
on visual function (Kuoppala et al.
2010). Another study at the Flinders
Medical Centre, Adelaide, South Aus-
tralia, evaluated the Impact of Cata-
ract Surgery (ICS) questionnaire using
Rasch analysis and concluded that in
its present form, it is unsuitable for
visual disability assessment in patients
before cataract surgery (Gothwal
et al. 2011).
There are two types of surgical inter-
vention that can be used to treat cata-
ract. Intracapsular cataract extraction
is a technique where the whole lens is
removed from the eye, and special eye-
glasses are necessary after the opera-
tion to restore vision. During extra-
capsular cataract extraction, the lens
and the front portion of the capsule
are removed and then replaced by an
artificial lens (Baltussen et al. 2004).
Cost-effectiveness analysis of cataract
surgery in Europe
Cataract surgery is estimated to be the
most common operative procedure
performed in developed countries
because of the growing volume of out-
patient surgeries (OECD 2005). It was
estimated that extra-capsular surgery
used with 95% coverage of the popu-
lation would avert more than 3.5 mil-
lions disability-adjusted life years
(DALY) per year globally (Baltussen
et al. 2004). A recent Finnish study
estimated that cataract surgery costs
€5128 per quality-adjusted life year
(QALY) gained in patients with both
eyes operated (Rasanen et al. 2006).
The number of cataract surgeries per-
formed in European countries varies
significantly, ranging from 265 per
100 000 people in Portugal to almost
1400 per 100 000 in Belgium in 2003
(Fattore & Torbica 2008). This varia-
tion can be probably explained by the
differences between demand side
(older population) and supply side
(capacities to perform cataract sur-
gery) across the countries. One of the
most recent studies of the cost of cata-
ract surgery in nine countries, includ-
ing 43 providers, showed that the
average length of stay at the hospital
ranged from 0.5 days in the Nether-
lands and England to 2.9 days in Ger-
many. On average, 90% of
interventions used soft lenses. Each
patient required approximately
199 min of direct care by healthcare
professionals, ranging from 130 min in
England and Germany to 321 min in
the Netherlands. The mean total cost
of the operation per patient was €714
(SD = €57) and ranged from €437 in
Denmark to €1087 in Italy. The mean
cost of the lens was €157 (SD = €57),
ranging from €135 in England to €217
in Spain. The variation in lens cost
was quite modest between countries.
The cost of direct healthcare labour
ranged from €82 in Hungary to €406
in France, and overheads ranged from
€20 in Hungary to €362 in Italy (Fat-
tore & Torbica 2008). In other studies,
the average cost of cataract surgery
was €1267 per eye operated in Finland
(Rasanen et al. 2006), €760 in Sweden
(Kobelt et al. 2002) and US$2525 in
the United States (Busbee et al. 2002).
Determinants of the cost of cataract sur-
gery between European countries
The explanatory regression model in
the study by Fattore and Torbica
showed that the type of technology
used (soft lenses), the amount of
labour time and the length of stay
were positively associated with total
costs (Fattore & Torbica 2008). Each
day of hospitalization increased the
total costs by 62%. Using soft lenses
rather than rigid ones for all patients
was associated with an increase in
total costs by 56%. Each additional
hour of labour time was associated
with a 10% increase. Therefore, per-
forming the intervention in an outpa-
tient hospital setting was associated
with a 60% reduction in the total cost
(Fattore & Torbica 2008).
The results of a global and regional
cost-effectiveness analysis of cataract
surgery showed that extra-capsular
cataract surgery dominates intracap-
sular cataract surgery and is
considered therefore to be the most
cost-effective intervention for cataract
control according to the Commission
on Macroeconomics and Health
(Health WCoMa 2001).
Discussion
The overall prevalence of cataract was
higher in Germany and Italy. It was
shown to increase with age in 2 ⁄3 of
cases being diagnosed at an age over
70 years. Sex-specific cataract preva-
lence was higher in women than in
men, although not all of the reviewed
studies were consistent in this aspect.
Sex-specific cataract prevalence in a
Spanish study was higher in men over
64 years of age than in women at the
same age (Navarro Esteban et al.
2007), and a case–control study from
Athens, Greece, found only borderline
significance of female sex to the risk
of cortical cataract (Theodoropoulou
et al. 2011). Several European epide-
miological studies showed that former
and current smoking, a history of car-
diovascular disease, family history of
ophthalmic disease, and higher expo-
sure to sunlight at the beach or at
work lead to increased risk of cata-
ract, whereas only one study showed
an association of increased cataract
risk with diabetes duration of 10 years
or longer, or with asthma and chronic
bronchitis. Importantly, this literature
review showed that chlorpromazine,
corticosteroids and multivitamin ⁄min-
eral formulation (PSC only) intake
increases the cataract risk depending
on dose, treatment application and
duration and therefore should be
taken into account together with
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patients’ morbidities and lifestyle fac-
tors, when prescribing medications
and testing new drugs.
The only effective treatment for cat-
aract at the moment is surgical inter-
vention. The healthcare costs for
cataract surgery varied significantly
between European countries, from
€318 in Hungary to €1267 in Finland.
Total costs of cataract surgery were
positively associated with the type of
technology used, the amount of
labour time, and the length of stay.
Performing the intervention in an out-
patient hospital setting was associated
with a 60% reduction in the total
cost.
This review was mostly focused on
the Caucasian population and there-
fore does not extensively discuss eth-
nic differences in prevalence and
incidence of cataract. Furthermore, a
comparison of prevalence and inci-
dence of cataract between different
countries in Europe should be made
with caution, because of different
diagnostic criteria or different age
group definitions used. Specifically,
for measuring the presence of cata-
racts, the studies utilized different
classification systems such as the Lens
Opacity Classification System II in
Casteldaccia eye study (Giuffre et al.
1994), and simplified cataract grading
system of the WHO cataract group
was used in study from Cuenca, Spain
(Navarro Esteban et al. 2007). Over-
all, reviewed studies used three types
of measurements for cataract: the
presence of VA deficit, the opacifica-
tion of the lens and its combination.
Cataract incidence is often hard to
estimate, as cataract onset is not
always possible to define. Neverthe-
less, strict inclusion criteria were used
to increase comparability between
reviewed studies. We have tried to
clarify where differences remain.
Previous literature reviews summa-
rized the impact of cataract on visual
impairment and blindness (Pascolini
et al. 2004; Resnikoff et al. 2004;
Pascolini & Mariotti 2011). Data on
prevalence and incidence were not
presented, and they failed to make a
comparison between different coun-
tries in Europe. Studies on cataract
surgery and its costs in Europe (Bus-
bee et al. 2002; Baltussen et al. 2004;
Rasanen et al. 2006) did not contain a
review of epidemiological data and
risk factors, whereas studies on risk
factors (Delcourt et al. 2000a,b;
OECD 2005) did not properly evalu-
ate the socio-economic importance of
cataract. The latest systematic review
on cataract prevalence was published
by Acosta et al. 2006 and reviewed
ten epidemiological studies, only three
of which were performed in Europe.
The systematic literature review
mostly focused on the prevalence of
cataract and its correlation with age
and sex, as well as on the comparison
of clinical definitions of cataract used
in different studies (Acosta et al.
2006). Despite the overall high impor-
tance of this review, many important
aspects of cataract epidemiology have
not been discussed.
Our review of experimental and
in vivo studies showed that cataract is
a result of oxidative stress induced by
light penetrating into the intraocular
space and consequent photochemical
reactions. A number of reviewed stud-
ies proposed that this process can be
inhibited by many nutritional and
metabolic oxyradical scavengers, such
as ascorbate, vitamin E, pyruvate, caf-
feine, NSAID and tempol. These asso-
ciations were extensively investigated
in rat and mouse lens organ culture
studies. In vivo studies on the possible
prevention of oxidative stress and cat-
aract formation have been conducted
by administering pyruvate and caf-
feine orally and by their topical appli-
cation using diabetic and galactosemic
animal models. Photosensitized dam-
age to lens caused by exposure to visi-
ble light and UVA has been found to
be significantly prevented by ascorbate
and pyruvate. Caffeine has been
found be effective against UVA and
UVB, whereas pyruvate was show to
be effective in prevention of cataract
induced by diabetes and galactosemia.
Tempol-H, with its strong antioxidant
activity, has been shown to be a
promising candidate for development
as an anti-cataract agent (Zigler et al.
2003). Results of our literature review
are in agreement with the recent over-
view of experimental studies on cata-
ract aetiology and cataract prevention
undertaken by Varma et al. (2011).
This review presented a comprehen-
sive overview of specific and general
cataract risk factors as well as an
update on most recent in vivo, experi-
mental studies and randomized con-
trol trials directed at investigating
pharmacological methods of cataract
prevention. Overall, this systematic
review showed that despite the high
effectiveness of cataract surgery for
cataract treatment, it still remains a
suboptimal alternative because of high
costs, potential side-effects and
increase in cataract incidence because
of population ageing and growth. Our
literature overview showed that there
are a number of comprehensive in vivo
and in vitro experimental studies on
cataract prevention, but only few
RCTs to prove similar effects on
humans were undertaken. No RCT
used adequate technique for early cat-
aract identification, which makes
results unreliable. More RCTs using
adequate early cataract detection
methodology such as photography of
the anterior eye segment according to
Scheimpflug’s principle are required.
The present meta-analysis presented
a comprehensive, concise and up-to-
date overview of the important
questions related to cataract such as
general and type-specific cataract risk
factors, epidemiology of cataract, cat-
aract treatment and its socio-economic
importance. Furthermore, we present
an overview of in vivo and in vitro
experimental studies and RCTs on
cataract prevention, as well as a short
overview of sensitive techniques for
cataract identification. Its authors
hope that the results of this literature
review will lead to increased aware-
ness in medical doctors, researchers
and the general population about cat-
aract risk factors and will lead to the
development of effective cataract pre-
ventive strategies.
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